UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of pharmacogenetics in capecitabine efficacy and toxicity

Cancer treatment reviews, 2016-11, Vol.50, p.9-22

2016

Volltextzugriff (PDF)

Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review

Cancer treatment reviews, 2015-12, Vol.41 (10), p.935-950

2015

Volltextzugriff (PDF)

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method

Annals of oncology, 2011-10, Vol.22 (10), p.2334-2341

2011

Volltextzugriff (PDF)

Effectiveness of mite-impermeable covers: a hypothesis-generating meta-analysis

Clinical and experimental allergy, 2014-12, Vol.44 (12), p.1473-1483

van Boven, F. E.

2014

Volltextzugriff (PDF)

Breast cancer classification by proteomic technologies: Current state of knowledge

Cancer treatment reviews, 2014-02, Vol.40 (1), p.129-138

2014

Volltextzugriff (PDF)

A reintroduction of environmental mite allergen control strategies for asthma treatment and the debate on their effectiveness

Clinical and experimental allergy, 2019-04, Vol.49 (4), p.400-409

2019

Volltextzugriff (PDF)

Effectiveness of the Air Purification Strategies for the Treatment of Allergic Asthma: A Meta-Analysis

International archives of allergy and immunology, 2020-05, Vol.181 (5), p.395-402

2020

Volltextzugriff (PDF)

Tolerance Induction in Cow's Milk Allergic Children by Heated Cow's Milk Protein: The iAGE Follow-Up Study

Nutrients, 2023-02, Vol.15 (5), p.1181

2023

Volltextzugriff (PDF)

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer

Breast cancer research and treatment, 2023-07, Vol.200 (2), p.271-279

2023

Volltextzugriff (PDF)

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

British journal of cancer, 2010-03, Vol.102 (5), p.803-809

2010

Volltextzugriff (PDF)

Differences in radio emission from similar M dwarfs in the binary system Ross 867-8

Astronomy and astrophysics (Berlin), 2020-01, Vol.633, p.A130

2020

Volltextzugriff (PDF)

House dust mite allergen avoidance strategies for the treatment of allergic asthma: A hypothesis-generating meta-analysis

The World Allergy Organization journal, 2024-06, Vol.17 (6), p.100919, Article 100919

2024

Volltextzugriff (PDF)

A meta‐analysis of baseline characteristics in trials on mite allergen avoidance in asthmatics: room for improvement

Clinical and translational allergy, 2020-01, Vol.10 (1), p.2-n/a, Article 2

2020

Volltextzugriff (PDF)

Homemade Food Allergen Extracts for Use in Skin Prick Tests in the Diagnosis of IgE-Mediated Food Allergy: A Good Alternative in the Absence of Commercially Available Extracts?

Nutrients, 2022-01, Vol.14 (3), p.475

2022

Volltextzugriff (PDF)

Characteristics of circulating tumor DNA (ctDNA) in patients with ER-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (MBC) on different lines of endocrine treatment

Annals of oncology, 2019-05, Vol.30, p.iii7-iii7

2019

Volltextzugriff (PDF)

Spontaneous remission of unidentified Cushing's disease revealed by hair cortisol analysis

Netherlands journal of medicine, 2020-09, Vol.78 (5), p.297-299

2020

Volltextzugriff (PDF)

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

Clinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.503-510

2012

Volltextzugriff (PDF)

Birch Pollen Related Pear Allergy: A Single-Blind Oral Challenge TRIAL with 2 Pear Cultivars

Nutrients, 2021-04, Vol.13 (4), p.1355

2021

Volltextzugriff (PDF)

Pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression in patients with HER2-positive metastatic breast cancer (MBC) - The PERNETTA trial (SAKK 22/10), a randomized open label phase II study (SAKK, UNICANCER, BOOG)

Annals of oncology, 2019-05, Vol.30, p.iii47-iii47

2019

Volltextzugriff (PDF)

Comparison of skin prick test and prick‐to‐prick test with fruits and vegetables in the diagnosis of food allergy

Clinical and translational allergy, 2024-07, Vol.14 (7), p.e12375-n/a

2024

Volltextzugriff (PDF)

PERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207)

Annals of oncology, 2018-10, Vol.29, p.viii93-viii93

2018

Volltextzugriff (PDF)

Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma

The pharmacogenomics journal, 2017-01, Vol.17 (1), p.42-46

2017

Volltextzugriff (PDF)

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

European journal of cancer (1990), 2014-12, Vol.50 (18), p.3077-3088

2014

Volltextzugriff (PDF)

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

British journal of cancer, 2008-07, Vol.99 (2), p.259-265

2008

Volltextzugriff (PDF)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

British journal of cancer, 2012-05, Vol.106 (11), p.1728-1734

2012

Volltextzugriff (PDF)

1 – 25 von 744

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(682)
Mit Volltextzugriff
(646)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The role of pharmacogenetics in capecitabine efficacy and toxicity

Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review

Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method

Effectiveness of mite-impermeable covers: a hypothesis-generating meta-analysis

Breast cancer classification by proteomic technologies: Current state of knowledge

A reintroduction of environmental mite allergen control strategies for asthma treatment and the debate on their effectiveness

Effectiveness of the Air Purification Strategies for the Treatment of Allergic Asthma: A Meta-Analysis

Tolerance Induction in Cow's Milk Allergic Children by Heated Cow's Milk Protein: The iAGE Follow-Up Study

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

Differences in radio emission from similar M dwarfs in the binary system Ross 867-8

House dust mite allergen avoidance strategies for the treatment of allergic asthma: A hypothesis-generating meta-analysis

A meta‐analysis of baseline characteristics in trials on mite allergen avoidance in asthmatics: room for improvement

Homemade Food Allergen Extracts for Use in Skin Prick Tests in the Diagnosis of IgE-Mediated Food Allergy: A Good Alternative in the Absence of Commercially Available Extracts?

Characteristics of circulating tumor DNA (ctDNA) in patients with ER-positive (ER+), HER2-negative (HER2-) metastatic breast cancer (MBC) on different lines of endocrine treatment

Spontaneous remission of unidentified Cushing's disease revealed by hair cortisol analysis

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced Hypertension

Birch Pollen Related Pear Allergy: A Single-Blind Oral Challenge TRIAL with 2 Pear Cultivars

Pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression in patients with HER2-positive metastatic breast cancer (MBC) - The PERNETTA trial (SAKK 22/10), a randomized open label phase II study (SAKK, UNICANCER, BOOG)

Comparison of skin prick test and prick‐to‐prick test with fruits and vegetables in the diagnosis of food allergy

PERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207)

Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Suchergebnisse filtern